CMCI is a biopharmaceutical company exploiting the ubiquitin system for the discovery and development of novel therapeutics.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Tel Aviv
State: Tel Aviv
Zip:
Country: Israel
Proteo Logics is a biopharmaceutical company exploiting the ubiquitin system for the discovery and development of novel therapeutics. Proteologics accomplishes this through identifying correlations between ubiquitin pathway components and pathological conditions.
Contact Phone:
Contact Email:
Listed Exchange:
TLV
IPO Date:
12/29/2016
Ticker Symbol:
CNMD
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2001 | Venture Round | 2 | $9M |
Concord Ventures Giza Venture Capital Concord Ventures Giza Venture Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|